1. Home
  2. MRSN vs KITT Comparison

MRSN vs KITT Comparison

Compare MRSN & KITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • KITT
  • Stock Information
  • Founded
  • MRSN 2001
  • KITT 2014
  • Country
  • MRSN United States
  • KITT United States
  • Employees
  • MRSN N/A
  • KITT N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • KITT Industrial Machinery/Components
  • Sector
  • MRSN Health Care
  • KITT Industrials
  • Exchange
  • MRSN Nasdaq
  • KITT Nasdaq
  • Market Cap
  • MRSN 37.0M
  • KITT 36.4M
  • IPO Year
  • MRSN 2017
  • KITT N/A
  • Fundamental
  • Price
  • MRSN $7.24
  • KITT $0.79
  • Analyst Decision
  • MRSN Strong Buy
  • KITT
  • Analyst Count
  • MRSN 4
  • KITT 0
  • Target Price
  • MRSN $63.67
  • KITT N/A
  • AVG Volume (30 Days)
  • MRSN 138.9K
  • KITT 1.5M
  • Earning Date
  • MRSN 08-13-2025
  • KITT 08-11-2025
  • Dividend Yield
  • MRSN N/A
  • KITT N/A
  • EPS Growth
  • MRSN N/A
  • KITT N/A
  • EPS
  • MRSN N/A
  • KITT N/A
  • Revenue
  • MRSN $34,769,000.00
  • KITT $3,082,232.00
  • Revenue This Year
  • MRSN N/A
  • KITT $2,936.06
  • Revenue Next Year
  • MRSN $1.03
  • KITT N/A
  • P/E Ratio
  • MRSN N/A
  • KITT N/A
  • Revenue Growth
  • MRSN 16.14
  • KITT N/A
  • 52 Week Low
  • MRSN $5.21
  • KITT $0.79
  • 52 Week High
  • MRSN $70.75
  • KITT $6.04
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 48.99
  • KITT 34.25
  • Support Level
  • MRSN $5.21
  • KITT $0.85
  • Resistance Level
  • MRSN $7.68
  • KITT $1.00
  • Average True Range (ATR)
  • MRSN 0.54
  • KITT 0.05
  • MACD
  • MRSN 0.12
  • KITT -0.01
  • Stochastic Oscillator
  • MRSN 81.04
  • KITT 1.28

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About KITT Nauticus Robotics Inc.

Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.

Share on Social Networks: